Synalgos (Caraco Pharma Inc.)
Welcome to the PulseAid listing for the Synalgos drug offered from Caraco Pharma Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Caraco Pharma Inc. |
NON-PROPRIETARY NAME: | Aspirin, Caffeine, and Dihydrocodeine Bitartrate Capsules |
SUBSTANCE NAME: | ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-12-30 |
END MARKETING DATE: | 0000-00-00 |
Synalgos HUMAN PRESCRIPTION DRUG Details:
Item Description | Synalgos from Caraco Pharma Inc. |
LABELER NAME: | Caraco Pharma Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 356.4; 30; 16(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2008-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49708-419_7f5a021d-7474-4639-92d8-bbb761737c87 |
PRODUCT NDC: | 49708-419 |
APPLICATION NUMBER: | NDA011483 |
Other ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE Pharmaceutical Manufacturers / Labelers: